What is the exact procedure for autologous serum therapy, including blood collection, serum preparation, and administration?

Autologous Serum Therapy: Exact Procedure

Autologous serum therapy involves collecting 10-50 mL of the patient's blood in plain tubes, allowing it to clot for 30-60 minutes at room temperature, centrifuging at 1500-2000 × g for 10 minutes at 4°C, then carefully pipetting the serum supernatant into sterile containers for immediate use or storage at -80°C. 1

Blood Collection

• Draw 10-50 mL of whole blood using standard venipuncture technique with appropriate needle gauge
• Use plain red-top tubes (glass tubes without additives) or serum separator tubes 1
• Critical step: If using non-glass tubes, gently invert the tubes 5 times immediately after blood draw to mix with clot activators 1
• Label tubes clearly with printed labels or barcodes (never handwritten) to prevent mix-ups 1
• Use proper personal protective equipment throughout the procedure 1

Serum Preparation

Clotting Phase

• Place filled tubes upright at room temperature for 30-60 minutes to allow complete clot formation 1
• This timing is critical and must be standardized across all samples 2
• If centrifugation cannot occur immediately after clotting, refrigerate at 4°C for no longer than 2 hours 1

Centrifugation

• Centrifuge at 1500-2000 × g for 10 minutes at 4°C 1
• Balance tubes by weight in the centrifuge to prevent equipment damage
• After centrifugation, three distinct layers form: serum (top), clot with cells (middle/bottom)

Serum Collection

• Use disposable transfer pipettes to carefully collect the serum (top layer) 1
• Critical technique: Gently draw liquid from the top, gradually moving the pipette down with the liquid level 1
• Avoid disturbing the clot containing red blood cells, white blood cells, and platelets 1
• Leave approximately 10% of serum at the bottom to prevent cross-layer contamination 1
• Transfer serum to a 15 mL conical tube (or 50 mL if collecting larger volumes) 1

Homogenization and Aliquoting

• If combining multiple tubes, pool all serum into the same conical tube 1
• Gently invert the conical tube 8-10 times to ensure homogeneity before aliquoting 1
• This step is essential because direct aliquoting from blood collection tubes causes heterogeneity among samples 1
• Aliquot 250 μL to 1 mL into labeled sterile microtubes or cryovials with O-ring-sealed screw caps 1

Storage and Handling

For Immediate Use (Ophthalmic Applications)

• Undiluted serum can be transferred directly into sterile drop bottles 3, 4
• Store at +4°C (refrigerator temperature) 3, 4
• Apply hourly during daytime for corneal conditions 3
• Sterility maintained up to 4 days when handled by trained personnel 4
• With prophylactic antibiotic drops, can be used up to 7 days (though 7.5% contamination rate observed at day 7) 4

For Long-Term Storage

• Store all aliquots upright in specimen boxes at -80°C or colder 1
• Use single-use aliquots to avoid freeze-thaw cycles which degrade bioactive components 1
• Properly stored serum maintains stability for extended periods

Administration Protocols

For Ocular Surface Disorders

• Apply undiluted autologous serum hourly during daytime 3
• Treatment duration typically 4-45 days (mean 16 days) until epithelial closure 3
• Success rate of 81% for corneal re-epithelialization 3
• Monitor for recurrence during 12-month follow-up 3

For Scalp/Hair Loss (Androgenetic Alopecia)

• Use 5-7 mL PRP (platelet-rich plasma variant), applying 0.05-0.1 mL/cm² 5
• Inject at 90-degree angle, 2-4 mm depth 5
• Space injections 1 cm apart in mapped areas of hair loss 5
• Treatment phase: 1 session every 4-6 weeks × 3 sessions per year 5
• Maintenance phase: 1 session every 6 months after initial year 5

Critical Quality Control Points

Hemolysis Prevention

• Hemolysis significantly deteriorates sample quality and is the primary cause of unusable specimens 1
• Inspect samples using a hemolysis reference chart (e.g., CDC Hemolysis Reference Palette) 1
• Document hemolysis scale during collection and verify during analysis 1

Contamination Prevention

• Good pipetting skills are essential for high-quality samples 1
• Maintain sterile technique throughout preparation
• When using insulin syringes for storage (low-resource settings), preparation and storage at +4°C with needle replacement between uses maintains sterility 6

Patient-Specific Considerations

• Patients on anticoagulants: May require modified protocols or be unsuitable candidates
• Contraindications: Active infection, severe anemia, coagulopathy
• Document all procedures and outcomes in patient records

Common Pitfalls to Avoid

1. Inadequate clotting time: Rushing the 30-60 minute clotting period results in incomplete serum separation
2. Disturbing the clot layer: Aggressive pipetting introduces cellular contamination
3. Skipping homogenization: Direct aliquoting without mixing creates inconsistent samples
4. Temperature fluctuations: Improper storage degrades growth factors and bioactive components
5. Multiple freeze-thaw cycles: Destroys therapeutic proteins
6. Poor labeling: Leads to dangerous patient identification errors